Scientific Bioprocessing, Inc to Exhibit at SIMB Annual Meeting 2021

Scientific Bioprocessing, Inc to Exhibit at SIMB Annual Meeting 2021

Scientific Bioprocessing, Inc to Exhibit at SIMB Annual Meeting


Scientific Bioprocessing, Inc. (SBI) will be exhibiting in person at the 71st annual Society for Industrial Microbiology and Biotechnology (SIMB) Meeting on August 8-11, 2021 in Austin, Texas. 

SBI will be showcasing its leading-edge microbial bioprocessing platform and products at SIMB. During the exhibition, you can connect with the SBI team and learn more about the company and its expanding microbiology and bioprocessing product line on the exhibit floor at booth #16. 

SBI will showcase to SIMB’s attendees the microbial capabilities of its powerful and disruptive Digitally Simplified Bioprocessing Platform. SBI’s new platform empowers research scientists to gather more data points in real time and in any vessel, while tapping into the vast potential of Big Data analytics. Digitally simplified bioprocessing occurs when the power of automated, leading-edge sensors, tools, and hardware meet powerful, intuitive software, creating a closed-loop system that can fully leverage the power of machine learning and artificial intelligence. 

SBI will be featuring several of the company’s leading-edge products at its in-person floor exhibit, including its Cell Growth Quantifier for Bioreactors, CGQ BioR, which powers non-invasive, online monitoring of biomass in bioreactors using backscatter measurements through a bioreactor’s optically clear wall. The company’s product suite also includes its Liquid Injection System (LIS) that automates the shake flask feeding process. In addition, the SBI team will also feature the Cell Growth Quantifier (CGQ), which is a smart sensor-based technology that offers highly parallelized, non-invasive online monitoring of biomass in shake flasks and other cultivation vessels. 

SIMB is one of the leading international professional societies in industrial microbiology and biotechnology. It has achieved this status by empowering its members and others to address current and future challenges facing humanity using industrial microbiology and biotechnology. 

SIMB has a long history dating back to the post-World War II era. In 1949, when microbiologists were searching for a place to showcase and publish their applied microbiology research, Dr. Walter Ezekiel, Bureau of Ordinance, Department of the Navy, Washington, DC, wrote to a number of individuals suggesting the formation of a new Society for Industrial Microbiology (SIM). On December 29, 1949, during the American Association for the Advancement of Science (AAAS) meeting in New York over 250 people met in the ballroom of the Hotel McAlpin in New York City where they decided to form a society in affiliation with the newly formed American Institute of Biological Sciences (AIBS). 

For more than 70 years, iterations of the SIMBs annual meeting have been a can’t miss event for key players in the applied microbial and biotechnology spaces. 

“The SIMB annual meeting is a wonderful opportunity for our team to showcase the value of our digitally simplified bioprocessing platform to those who can benefit from it the most. We are at an exciting inflection point in our company’s history. We can now offer a suite of tools that leverage highly flexible, high performance optical sensors with dynamic, Big Data software analytics to fundamentally enhance bioprocessing and the efficiency of the drug development process,” stated John Moore, President of SBI. 

“We are really looking forward to engaging our colleagues in person at the SIMB meeting. It will be refreshing to meet face-to-face and gather valuable feedback on how we can help them generate new scientific insights while achieving their research objectives more efficiently,” he added.         

Make sure to visit SBI at booth #16 to meet the team and learn more about the Digitally Simplified Bioprocessing platform that’s poised to unleash the full potential of bioprocessing to help deliver more life-saving medicines to patients in need across the globe.